Biosecurity
Biosecurity has become central to biotechnology governance with the post-COVID policy attention. The session covers dual-use research of concern (DURC) frameworks, synthetic biology screening including DNA-synthesis order screening, pandemic preparedness through 100 Days Mission and the Biological Weapons Convention, lab biosafety and BSL-3/4 oversight, AI risks in biology (the AI-bioweapon vulnerability research), and international biosecurity frameworks post-COVID. Discussion addresses the gain-of-function research debate, biosurveillance through wastewater and metagenomics, biosecurity capacity-building in LMICs, the One Health surveillance framework integrating human, animal and environmental data, and emerging biothreat horizon scanning.
- DURC frameworks
- DNA-synthesis screening
- 100 Days Mission
- Lab biosafety BSL-3/4
- AI-bioweapon vulnerability
- Gain-of-function debate
- Wastewater biosurveillance
- Biothreat horizon scanning
Explore the full GSBG 2027 program
- 01Synthetic Biology & Biomanufacturing
- 02Genetic Engineering & CRISPR
- 03Tissue Engineering & Biomaterials
- 04Medical Devices & Sensors
- 05Bioinformatics & Computational Biology
- 06Drug Delivery Systems
- 07Biomechanics & Prosthetics
- 08Regulatory & Bioethics
- 09Industrial Biotechnology
- 10AI in Drug Discovery
- 11Cell & Gene Therapy
- 12Stem Cell Research
- 13Antibody-Drug Conjugates
- 14Vaccines & Immunotherapy
- 15Microbiome Engineering
- 16Nanomedicine
- 17Personalized Medicine
- 18Bioethics & Governance
- 19Marine Biotechnology
- 20Plant Biotechnology
- 21Agricultural Biotech
- 22Environmental Biotech
- 23Single-Cell Biology
- 24Spatial Biology
- 25Organoids & Organ-on-Chip
- 26Lab Automation
- 28Synthetic Genomics
- 29Bioprinting
- 30Biosensors & Diagnostics
- 31Liquid Biopsy
- 32Multi-Cancer Early Detection
- 33Continuous Biomanufacturing
- 34Decentralised Manufacturing
- 35RNA Editing